Gene expression profiles in an hepatitis B virus transfected hepatoblastoma cell line and differentially regulated gene expression by interferon-alpha
- PMID: 15188497
- PMCID: PMC4572260
- DOI: 10.3748/wjg.v10.i12.1740
Gene expression profiles in an hepatitis B virus transfected hepatoblastoma cell line and differentially regulated gene expression by interferon-alpha
Abstract
Aim: To study interactions between hepatitis B virus (HBV) and interferon-alpha in liver- derived cells.
Methods: mRNAs were separately isolated from an HBV-transfected cell line (HepG(2)2.2.15) and its parental cell line (HepG(2)) pre- and post-interferon-alpha (IFN-alpha) treatment at 6, 24 and 48 h, followed by hybridization with a cDNA microarray filter dotted with 14 000 human genes. After hybridization and scanning of the arrays, the data were analyzed using ArrayGauge software. The microarray data were further verified by Northern blot analysis.
Results: Compared to HepG(2) cells, 14 genes with known functions were down-regulated 3 to 12- magnitudes, while 7 genes were up-regulated 3-13 magnitudes in HepG(2)2.2.15 cells prior to IFN-alpha treatment. After interferon-alpha treatment, the expression of four genes (vascular endothelial growth factor, tyrosine phosphate 1E, serine protein with IGF-binding motif and one gene of clathrin light chain) in HepG(2)2.2.15 were up-regulated, while one gene encoding a GTP-binding protein, two genes of interferon-induced kinases and two proto-oncogenes were further down- regulated. Interestingly, under IFN-alpha treatment, a number of differentially regulated genes were new ESTs or genes with unknown functions.
Conclusion: The up-regulated genes in HepG(2)2.2.15 cell line suggested that under IFN-alpha treatment, these repressed cellular genes in HBV infected hepatocytes could be partially restored, while the down- regulated genes were most likely the cellular genes which could not be restored under interferon treatment. These down-regulated genes identified by microarray analysis could serve as new targets for anti-HBV drug development or for novel therapies.
Figures

Similar articles
-
Analysis of gene expression in hepatitis B virus transfected cell line induced by interferon.Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003 Dec;35(12):1053-60. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2003. PMID: 14673494
-
Role of ISGF3 in modulating the anti-hepatitis B virus activity of interferon-alpha in vitro.J Gastroenterol Hepatol. 2008 Nov;23(11):1747-61. doi: 10.1111/j.1440-1746.2007.04985.x. Epub 2007 Jun 7. J Gastroenterol Hepatol. 2008. PMID: 17559358
-
Thymosin-alpha 1, but not interferon-alpha, specifically inhibits anchorage-independent growth of hepatitis B viral transfected HepG2 cells.J Hepatol. 1996 Dec;25(6):814-20. doi: 10.1016/s0168-8278(96)80283-2. J Hepatol. 1996. PMID: 9007707
-
Interferon-alpha response in chronic hepatitis B-transfected HepG2.2.15 cells is partially restored by lamivudine treatment.World J Gastroenterol. 2007 Jan 14;13(2):228-35. doi: 10.3748/wjg.v13.i2.228. World J Gastroenterol. 2007. PMID: 17226901 Free PMC article.
-
Interferon-stimulated gene of 20 kDa protein (ISG20) degrades RNA of hepatitis B virus to impede the replication of HBV in vitro and in vivo.Oncotarget. 2016 Oct 18;7(42):68179-68193. doi: 10.18632/oncotarget.11907. Oncotarget. 2016. PMID: 27626689 Free PMC article.
Cited by
-
Gene expression profiling reveals similarities between the in vitro and in vivo responses of immune effector cells to IFN-alpha.Clin Cancer Res. 2008 Sep 15;14(18):5900-6. doi: 10.1158/1078-0432.CCR-08-0846. Clin Cancer Res. 2008. PMID: 18794103 Free PMC article.
-
Specific delivery of microRNA93 into HBV-replicating hepatocytes downregulates protein expression of liver cancer susceptible gene MICA.Oncotarget. 2014 Jul 30;5(14):5581-90. doi: 10.18632/oncotarget.2143. Oncotarget. 2014. PMID: 25026299 Free PMC article.
References
-
- Hoofnagle JH. Alpha-interferon therapy of chronic hepatitis B. Current status and recommendations. J Hepatol. 1990;11(Suppl 1):S100–S107. - PubMed
-
- Korenman J, Baker B, Waggoner J, Everhart JE, Di Bisceglie AM, Hoofnagle JH. Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med. 1991;114:629–634. - PubMed
-
- Caselmann WH, Eisenburg J, Hofschneider PH, Koshy R. Beta- and gamma-interferon in chronic active hepatitis B. A pilot trial of short-term combination therapy. Gastroenterology. 1989;96:449–455. - PubMed
-
- Wen YM, Qian LS, Lou HZ, Gao JQ, Wu XH, Yang PZ. Stud-ies on production of interferon I by peripheral blood mono-nuclear cells in chronic hepatitis B patients. Chin Med J. 1980;60:239–241.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical